- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued based on future growth
Global Pharmaceuticals & Biotech Undervalued based on future growth
Results
46
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
46 companies
PharmaEssentia
Market Cap: NT$189.4b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$512.00
7D
3.4%
1Y
-21.3%
Indivior
Market Cap: US$4.4b
Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
INDV
US$35.44
7D
-0.8%
1Y
199.1%
China Resources Pharmaceutical Group
Market Cap: HK$29.0b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.61
7D
2.2%
1Y
-12.9%
Hypera
Market Cap: R$14.7b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$23.56
7D
1.0%
1Y
32.2%
Lotus Pharmaceutical
Market Cap: NT$76.9b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$292.50
7D
3.7%
1Y
10.0%
Harmony Biosciences Holdings
Market Cap: US$2.2b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$38.55
7D
3.1%
1Y
13.9%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥15.5b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥9.57
7D
6.0%
1Y
-21.2%
Organon
Market Cap: US$2.1b
Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$8.05
7D
11.2%
1Y
-49.2%
Bora Pharmaceuticals
Market Cap: NT$64.1b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$517.00
7D
5.1%
1Y
-22.6%
Pacific Shuanglin Bio-pharmacy
Market Cap: CN¥13.6b
Engages in research, development, production, and sales of blood products in China and internationally.
000403
CN¥14.35
7D
4.8%
1Y
-11.2%
Neuren Pharmaceuticals
Market Cap: AU$2.4b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$19.22
7D
1.6%
1Y
61.4%
Collegium Pharmaceutical
Market Cap: US$1.5b
A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
COLL
US$45.54
7D
0.02%
1Y
38.4%
Alvotech
Market Cap: US$1.5b
Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.
ALVO
US$4.64
7D
-7.2%
1Y
-65.7%
Shanghai Haohai Biological Technology
Market Cap: HK$10.7b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$25.68
7D
5.7%
1Y
4.2%
L&C BIOLTD
Market Cap: ₩1.5t
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.
A290650
₩62,300.00
7D
-0.2%
1Y
133.3%
Strides Pharma Science
Market Cap: ₹86.8b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.
STAR
₹941.85
7D
4.6%
1Y
45.5%
Genomma Lab Internacional. de
Market Cap: Mex$16.9b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
LAB B
Mex$17.64
7D
-1.6%
1Y
-33.2%
Newron Pharmaceuticals
Market Cap: CHF 608.4m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 30.40
7D
27.5%
1Y
242.3%
Tong Ren Tang Technologies
Market Cap: HK$5.8b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.49
7D
1.1%
1Y
-6.8%
Emergent BioSolutions
Market Cap: US$701.7m
A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.
EBS
US$12.96
7D
3.6%
1Y
31.2%
CorMedix
Market Cap: US$591.7m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.63
7D
-37.3%
1Y
-31.8%
Medy-Tox
Market Cap: ₩842.4b
Operates as a biopharmaceutical company in South Korea.
A086900
₩120,000.00
7D
-2.0%
1Y
-3.9%
DongKook Pharmaceutical
Market Cap: ₩753.4b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩16,840.00
7D
-1.4%
1Y
6.2%
Zevra Therapeutics
Market Cap: US$485.8m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$8.49
7D
1.8%
1Y
4.7%
SIGA Technologies
Market Cap: US$484.8m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$6.61
7D
5.4%
1Y
6.4%
Dong-A Socio Holdings
Market Cap: ₩686.0b
Engages in the pharmaceutical business in South Korea.
A000640
₩106,600.00
7D
-1.0%
1Y
9.4%
Blau Farmacêutica
Market Cap: R$2.4b
A pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.
BLAU3
R$10.41
7D
-2.7%
1Y
6.9%
Clinuvel Pharmaceuticals
Market Cap: AU$634.5m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$12.64
7D
-0.6%
1Y
9.5%
Orchid Pharma
Market Cap: ₹36.9b
A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.
ORCHPHARMA
₹728.50
7D
-8.3%
1Y
-60.5%
Beximco Pharmaceuticals
Market Cap: ৳47.6b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.
BXPHARMA
৳106.80
7D
4.8%
1Y
36.6%
Essex Bio-Technology
Market Cap: HK$2.4b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.16
7D
9.2%
1Y
49.6%
JBM (Healthcare)
Market Cap: HK$2.3b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.77
7D
4.5%
1Y
61.0%
Egyptian International Pharmaceutical Industries
Market Cap: ج.م13.5b
Manufactures and sells pharmaceutical ampoules in Egypt and internationally.
PHAR
ج.م80.00
7D
3.2%
1Y
73.2%
Abeona Therapeutics
Market Cap: US$275.8m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$5.19
7D
-2.3%
1Y
-6.5%
Laboratorio Reig Jofre
Market Cap: €214.9m
A pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food.
RJF
€2.64
7D
-1.5%
1Y
1.1%
Coherus Oncology
Market Cap: US$184.9m
A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
CHRS
US$1.69
7D
23.4%
1Y
15.0%